WARREN, N.J. (AP) — WARREN, N.J. (AP) — Aquestive Therapeutics Inc. (AQST) on Wednesday reported a loss of $15.4 million in its third quarter.
The Warren, New Jersey-based company said it had a loss of 14 cents per share.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The specialty pharmaceutical company posted revenue of $12.8 million in the period, which also fell short of Street forecasts. Six analysts surveyed by Zacks expected $13.4 million.
Aquestive Therapeutics shares have increased 69% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6, an increase of 26% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
